Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats

Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, and Fructus Gardeniae are often used alongside with clozapine (CLZ) for schizophrenia patients in order to reduce side effects and enhance therapeutic efficacy. However, worse outcomes were observed raising concern about a critical issue, herb-d...

Full description

Bibliographic Details
Main Authors: Dan-Dan Tian, Wei Wang, Hua-Ning Wang, Stephen Cho Wing Sze, Zhang-Jin Zhang
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/6/696
_version_ 1828484950498738176
author Dan-Dan Tian
Wei Wang
Hua-Ning Wang
Stephen Cho Wing Sze
Zhang-Jin Zhang
author_facet Dan-Dan Tian
Wei Wang
Hua-Ning Wang
Stephen Cho Wing Sze
Zhang-Jin Zhang
author_sort Dan-Dan Tian
collection DOAJ
description Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, and Fructus Gardeniae are often used alongside with clozapine (CLZ) for schizophrenia patients in order to reduce side effects and enhance therapeutic efficacy. However, worse outcomes were observed raising concern about a critical issue, herb-drug interactions, which were rarely reported when antipsychotics were included. This study aims to determine whether the concomitant use of these herbal medicines affects the pharmacokinetic characteristics of CLZ in rat models. Rats were given a single or multiple intraperitoneal injections of 10 mg/kg CLZ, either alone or with individual herbal water extracts administered orally. CLZ and its two inactive metabolites, norclozapine and clozapine N-oxide, were determined by high-performance liquid chromatography/tandem mass spectrometry. In the acute treatment, the formation of both metabolites was reduced, while no significant change was observed in the CLZ pharmacokinetics for any of the herbal extracts. In the chronic treatment, none of the four herbal extracts significantly influenced the pharmacokinetic parameters of CLZ and its metabolites. Renal and liver functions stayed normal after the 11-day combined use of herbal medicines. Overall, the four herbs had limited interaction effect on CLZ pharmacokinetics in the acute and chronic treatment. Herb-drug interaction includes both pharmacokinetic and pharmacodynamic mechanisms. This result gives us a hint that pharmacodynamic herb-drug interaction, instead of pharmacokinetic types, may exist and need further confirmation.
first_indexed 2024-12-11T09:04:43Z
format Article
id doaj.art-ac80339185124e0a826c8848da87c23f
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-11T09:04:43Z
publishDate 2016-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-ac80339185124e0a826c8848da87c23f2022-12-22T01:13:40ZengMDPI AGMolecules1420-30492016-05-0121669610.3390/molecules21060696molecules21060696Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in RatsDan-Dan Tian0Wei Wang1Hua-Ning Wang2Stephen Cho Wing Sze3Zhang-Jin Zhang4School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, ChinaSchool of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, ChinaDepartment of Psychiatry, the fourth Military Medical University, Xi’an 710032, Shaanxi, ChinaSchool of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, ChinaSchool of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, ChinaRadix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, and Fructus Gardeniae are often used alongside with clozapine (CLZ) for schizophrenia patients in order to reduce side effects and enhance therapeutic efficacy. However, worse outcomes were observed raising concern about a critical issue, herb-drug interactions, which were rarely reported when antipsychotics were included. This study aims to determine whether the concomitant use of these herbal medicines affects the pharmacokinetic characteristics of CLZ in rat models. Rats were given a single or multiple intraperitoneal injections of 10 mg/kg CLZ, either alone or with individual herbal water extracts administered orally. CLZ and its two inactive metabolites, norclozapine and clozapine N-oxide, were determined by high-performance liquid chromatography/tandem mass spectrometry. In the acute treatment, the formation of both metabolites was reduced, while no significant change was observed in the CLZ pharmacokinetics for any of the herbal extracts. In the chronic treatment, none of the four herbal extracts significantly influenced the pharmacokinetic parameters of CLZ and its metabolites. Renal and liver functions stayed normal after the 11-day combined use of herbal medicines. Overall, the four herbs had limited interaction effect on CLZ pharmacokinetics in the acute and chronic treatment. Herb-drug interaction includes both pharmacokinetic and pharmacodynamic mechanisms. This result gives us a hint that pharmacodynamic herb-drug interaction, instead of pharmacokinetic types, may exist and need further confirmation.http://www.mdpi.com/1420-3049/21/6/696herbal medicineclozapinepharmacokineticsherb-drug interactionmetabolism
spellingShingle Dan-Dan Tian
Wei Wang
Hua-Ning Wang
Stephen Cho Wing Sze
Zhang-Jin Zhang
Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
Molecules
herbal medicine
clozapine
pharmacokinetics
herb-drug interaction
metabolism
title Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
title_full Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
title_fullStr Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
title_full_unstemmed Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
title_short Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
title_sort pharmacokinetic evaluation of clozapine in concomitant use of radix rehmanniae fructus schisandrae radix bupleuri or fructus gardeniae in rats
topic herbal medicine
clozapine
pharmacokinetics
herb-drug interaction
metabolism
url http://www.mdpi.com/1420-3049/21/6/696
work_keys_str_mv AT dandantian pharmacokineticevaluationofclozapineinconcomitantuseofradixrehmanniaefructusschisandraeradixbupleuriorfructusgardeniaeinrats
AT weiwang pharmacokineticevaluationofclozapineinconcomitantuseofradixrehmanniaefructusschisandraeradixbupleuriorfructusgardeniaeinrats
AT huaningwang pharmacokineticevaluationofclozapineinconcomitantuseofradixrehmanniaefructusschisandraeradixbupleuriorfructusgardeniaeinrats
AT stephenchowingsze pharmacokineticevaluationofclozapineinconcomitantuseofradixrehmanniaefructusschisandraeradixbupleuriorfructusgardeniaeinrats
AT zhangjinzhang pharmacokineticevaluationofclozapineinconcomitantuseofradixrehmanniaefructusschisandraeradixbupleuriorfructusgardeniaeinrats